Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Viracta Therapeutics Inc (VIRX)

Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Wall street sign in New York City with American flags and New York Stock Exchange in background by kasto80 via iStock
Stock Index Futures Slip on Pressure from Rising Bond Yields Barchart - Fri Dec 27, 4:43AM CST

March S&P 500 E-Mini futures (ESH25) are down -0.36%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.40% this morning, following Thursday’s muted session on Wall Street, as rising Treasury yields...

TGT : 135.50 (-0.65%)
MSTR : 330.00 (-3.24%)
MARA : 18.44 (-4.46%)
DLTR : 75.99 (-0.26%)
ABAT : 3.36 (+7.01%)
CRKN : 0.1430 (+8.58%)
ESH25 : 6,027.00s (-1.12%)
UNH : 509.99 (-0.23%)
VIRX : 0.1600 (-32.49%)
NQH25 : 21,698.50s (-1.41%)
BTBT : 3.18 (-4.50%)
GME : 32.20 (-2.39%)
Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives GlobeNewswire - Thu Dec 26, 3:30PM CST

VIRX : 0.1600 (-32.49%)
Sunesis: Q3 Earnings Snapshot AP - Wed Nov 13, 6:14AM CST

Sunesis: Q3 Earnings Snapshot

VIRX : 0.1600 (-32.49%)
Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Wed Nov 13, 6:00AM CST

VIRX : 0.1600 (-32.49%)
Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma GlobeNewswire - Wed Nov 6, 3:30PM CST

VIRX : 0.1600 (-32.49%)
Sunesis: Q2 Earnings Snapshot AP - Wed Aug 14, 6:13AM CDT

Sunesis: Q2 Earnings Snapshot

VIRX : 0.1600 (-32.49%)
Viracta Therapeutics Announces Chief Executive Officer Leadership Succession to Drive the Next Phase of the Company's Strategic Development and Growth PR Newswire - Mon Sep 19, 2022

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the succession...

VIRX : 0.1600 (-32.49%)
Viracta Therapeutics Chief Scientific Officer, Dr. Ayman Elguindy, Elected to the Governing Board of the International Association for Research on Epstein-Barr Virus and Associated Diseases PR Newswire - Tue Aug 16, 2022

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the...

VIRX : 0.1600 (-32.49%)
Viracta Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates PR Newswire - Tue Aug 9, 2022

Continued progress of NAVAL-1, the pivotal trial of Nana-val for the treatment of Epstein-Barr virus-positive (EBV+) lymphoma; update on the initial cohort(s)...

VIRX : 0.1600 (-32.49%)
Viracta Therapeutics President and Chief Executive Officer Dr. Ivor Royston Receives the Science History Institute's Biotechnology Heritage Award PR Newswire - Mon Jun 13, 2022

/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that its...

VIRX : 0.1600 (-32.49%)

Barchart Exclusives

Is FedEx Stock a Buy, Sell, or Hold Ahead of Its Freight Spinoff? Barchart - Sat Dec 28, 10:00AM CST
Following FedEx’s move to spin off its freight division, does the stock present a compelling buy for investors, or is patience the wiser course? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot